Soleno Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Soleno Therapeutics Stock Summary

Soleno Therapeutics competes with Annexon, Bolt Biotherapeutics, Lyra Therapeutics, Pulmatrix, and Capricor Therapeutics. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. Soleno Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.

Soleno Therapeutics Key Financial Ratios

Soleno Therapeutics Key Balance Sheet Accounts

Soleno Therapeutics Key Cash Accounts

Soleno Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Soleno Therapeutics's current stock value. Our valuation model uses many indicators to compare Soleno Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Soleno Therapeutics competition to find correlations between indicators driving Soleno Therapeutics's intrinsic value. More Info.Soleno Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Soleno Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Soleno Therapeutics' earnings, one of the primary drivers of an investment's value.

Soleno Therapeutics Systematic Risk

Today, most investors in Soleno Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Soleno Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Soleno Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Soleno Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Soleno Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Soleno Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Soleno Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Soleno Therapeutics's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.